Latest / Let's Talk Alzheimer's
Trontinemab: A New Brain-Penetrant Alzheimer’s Therapy | Dr. Gil Rabinovici
A new generation of Alzheimer’s therapies is tackling one of medicine’s toughest challenges: delivering drugs to the brain. Renowned Alzheimer’s researcher Dr. Gil Rabinovici explores trontinemab, an investigational anti-amyloid therapy being studied for early Alzheimer’s disease that uses innovative Brainshuttle™ technology to enhance drug delivery across the blood-brain barrier. He also shares insights from the TRONTIER 1 and 2 clinical trials, the TRAVELLER pre-screening study, and the ambitious PrevenTRON prevention study, which is exploring whether early treatment may help stop or…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.